Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06390488
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-30
First Post:
2024-04-01
Brief Title:
Transcutaneous Medial Plantar Nerve Stimulation in Women With Idiopathic Overactive Bladder
Sponsor:
Pamukkale University
Organization:
Pamukkale University
Study Overview
Official Title:
Transcutaneous Medial Plantar Nerve Stimulation in Women With Idiopathic Overactive Bladder A Prospective Randomized Double-blind Placebo Controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators conducted a prospective randomized double-blind placebo-controlled study based on a placebo technique to evaluate the efficacy of T-MPNS vs placebo in women with idiopathic OAB
The main questions aimed to be answered are
What are the effects of Transcutaneous Medial Plantar Nerve Stimulation T-MPSS on clinical parameters related to incontinence and quality of life compared to the placebo group in women with idiopathic overactive bladder OAB Participants n40 with idiopathic OAB who meet the exclusion and inclusion criteria will be divided into 2 groups using a randomization table The first group will receive T-MPSS n20 and the second group will receive placebo T-MPSS n20 Measurements will be performed twice in total before and at the end of treatment 6th week
The main questions aimed to be answered are
What are the effects of Transcutaneous Medial Plantar Nerve Stimulation T-MPSS on clinical parameters related to incontinence and quality of life compared to the placebo group in women with idiopathic overactive bladder OAB Participants n40 with idiopathic OAB who meet the exclusion and inclusion criteria will be divided into 2 groups using a randomization table The first group will receive T-MPSS n20 and the second group will receive placebo T-MPSS n20 Measurements will be performed twice in total before and at the end of treatment 6th week
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None